lystn

A new cohort of obesity drugs, called GLP1 receptor agonists, are so effective and safe that they will likely be put into widespread use for the treatment of obesity and achieve unparalleled success in the treatment of this disease—on par with bariatric surgery, but without the surgery. In this video I discuss the latest science and the promise of these drugs—as well as two other new classes of drugs that show similar (and synergistic) promise.

===

Like, comment, subscribe.

For more, find me at:

PODCAST The Kevin Bass Show

YOUTUBE https://www.youtube.com/user/kbassphiladelphia

WEBSITE http://thedietwars.com

TWITTER https://twitter.com/kevinnbass/

https://twitter.com/healthmisinfo/

INSTAGRAM https://instagram.com/kevinnbass/

TIKTOK https://tiktok.com/@kevinnbass

And above all, please donate to support what I do:

PATREON https://patreon.com/kevinnbass/

DONATE https://thedietwars.com/support-me/